NCT01709370 2013-12-31Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenOrganisation for Oncology and Translational ResearchPhase 2 Unknown45 enrolled